A massive dose of vincristine

Koutarou Maeda, Masaaki Ueda, Hitoshi Ohtaka, Yoshimasa Koyama, Masahiro Ohgami, Hiroshi Miyazaki

Research output: Contribution to journalArticlepeer-review

Abstract

An esophageal cancer patient with bilateral lungs and neck lymph nodes metastases received 24 mg of vincristine instead of vinblastine because of the similarity between the two names, and survived multlorgan derangement. Serious states of central and peripheral neuropathy with muscle atrophy, gastrointestinal disorder, bone marrow suppression and mucocutaneous involvement were all encountered. Although hypotension and syndrome of inappropriate secretion of antidiuretic hormone (SIADH) were not observed as vincristlne's side actions, toxicity to the myocardium, which has not been documented, was suggested in our case. These toxic impairments, however, subsided clinically within a month, except for paresthesia in the peripheral extremities. The effectiveness of the chemotherapy was remarkable against both the esophageal cancer and the metastatic lesions. No unintentional overdose of a drug, needless to say, should happen, and in order to minimize its possibility, it would be advisable for chemotherapy to be administered only by an experienced physician who is able to check the dose and concentration.

Original languageEnglish
Pages (from-to)247-253
Number of pages7
JournalJapanese journal of clinical oncology
Volume17
Issue number3
Publication statusPublished - 09-1987
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint Dive into the research topics of 'A massive dose of vincristine'. Together they form a unique fingerprint.

Cite this